162 related articles for article (PubMed ID: 15917448)
21. Chemotaxis of human monocyte-derived dendritic cells to complement component C1q is mediated by the receptors gC1qR and cC1qR.
Vegh Z; Kew RR; Gruber BL; Ghebrehiwet B
Mol Immunol; 2006 Mar; 43(9):1402-7. PubMed ID: 16140380
[TBL] [Abstract][Full Text] [Related]
22. Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate.
Kitamei H; Iwabuchi K; Namba K; Yoshida K; Yanagawa Y; Kitaichi N; Kitamura M; Ohno S; Onoé K
J Leukoc Biol; 2006 Jun; 79(6):1193-201. PubMed ID: 16574770
[TBL] [Abstract][Full Text] [Related]
23. Experimental autoimmune uveoretinitis initiated by non-phagocytic destruction of inner segments of photoreceptor cells by Mac-1(+) mononuclear cells.
Miura-Takeda S; Tashiro-Yamaji J; Oku H; Takahashi T; Shimizu T; Sugiyama T; Ikeda T; Kubota T; Yoshida R
Microbiol Immunol; 2008 Dec; 52(12):601-10. PubMed ID: 19120974
[TBL] [Abstract][Full Text] [Related]
24. Rat models of autoimmune uveitis.
Wildner G; Diedrichs-Mohring M; Thurau SR
Ophthalmic Res; 2008; 40(3-4):141-4. PubMed ID: 18421228
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic potential of self-antigen-specific CD4+ CD25+ regulatory T cells selected in vitro from a polyclonal repertoire.
Fisson S; Djelti F; Trenado A; Billiard F; Liblau R; Klatzmann D; Cohen JL; Salomon BL
Eur J Immunol; 2006 Apr; 36(4):817-27. PubMed ID: 16525991
[TBL] [Abstract][Full Text] [Related]
26. Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential.
Hoffmann MH; Trembleau S; Muller S; Steiner G
J Autoimmun; 2010 May; 34(3):J178-206. PubMed ID: 20031372
[TBL] [Abstract][Full Text] [Related]
27. Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes.
Lo J; Peng RH; Barker T; Xia CQ; Clare-Salzler MJ
Ann N Y Acad Sci; 2006 Oct; 1079():153-6. PubMed ID: 17130547
[TBL] [Abstract][Full Text] [Related]
28. Treating autoimmune diseases through restoration of antigen-specific immune tolerance.
Wolfraim LA
Arch Immunol Ther Exp (Warsz); 2006; 54(1):1-13. PubMed ID: 16642252
[TBL] [Abstract][Full Text] [Related]
29. Do tissue levels of autoantigenic aminoacyl-tRNA synthetase predict clinical disease?
Kron MA; Petridis M; Haertlein M; Libranda-Ramirez B; Scaffidi LE
Med Hypotheses; 2005; 65(6):1124-7. PubMed ID: 16085368
[TBL] [Abstract][Full Text] [Related]
30. Physiological roles of murine DAP10 adapter protein in tumor immunity and autoimmunity.
Hyka-Nouspikel N; Phillips JH
Immunol Rev; 2006 Dec; 214():106-17. PubMed ID: 17100879
[TBL] [Abstract][Full Text] [Related]
31. C-type lectins on dendritic cells: key modulators for the induction of immune responses.
van Kooyk Y
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1478-81. PubMed ID: 19021579
[TBL] [Abstract][Full Text] [Related]
32. A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth.
Bei R; Masuelli L; Palumbo C; Modesti M; Modesti A
Cancer Lett; 2009 Aug; 281(1):8-23. PubMed ID: 19091462
[TBL] [Abstract][Full Text] [Related]
33. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M).
Kaushansky N; Eisenstein M; Oved JH; Ben-Nun A
Int Immunol; 2008 Nov; 20(11):1439-49. PubMed ID: 18801757
[TBL] [Abstract][Full Text] [Related]
34. Dendritic cells and their role in cancer immunotherapy.
Jalili A
Iran J Immunol; 2007 Sep; 4(3):127-44. PubMed ID: 17767012
[TBL] [Abstract][Full Text] [Related]
35. Mature monocyte-derived dendritic cells respond more strongly to CCL19 than to CXCL12: consequences for directional migration.
Humrich JY; Humrich JH; Averbeck M; Thumann P; Termeer C; Kämpgen E; Schuler G; Jenne L
Immunology; 2006 Feb; 117(2):238-47. PubMed ID: 16423060
[TBL] [Abstract][Full Text] [Related]
36. The immunogenicity of dendritic cell-derived exosomes.
Quah BJ; O'Neill HC
Blood Cells Mol Dis; 2005; 35(2):94-110. PubMed ID: 15975838
[TBL] [Abstract][Full Text] [Related]
37. [Studies on autoantigenic epitopes involving in the development of uveitis].
Zhao CL; Yang PZ
Zhonghua Yan Ke Za Zhi; 2008 Apr; 44(4):377-80. PubMed ID: 18844025
[TBL] [Abstract][Full Text] [Related]
38. Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases.
Ardesjö B; Hansson CM; Bruder CE; Rorsman F; Betterle C; Dumanski JP; Kämpe O; Ekwall O
J Autoimmun; 2008 Jun; 30(4):273-82. PubMed ID: 18242955
[TBL] [Abstract][Full Text] [Related]
39. Chemokine receptor CXCR3: an unexpected enigma.
Liu L; Callahan MK; Huang D; Ransohoff RM
Curr Top Dev Biol; 2005; 68():149-81. PubMed ID: 16124999
[TBL] [Abstract][Full Text] [Related]
40. Osteopontin is proinflammatory in experimental autoimmune uveitis.
Hikita ST; Vistica BP; Jones HR; Keswani JR; Watson MM; Ericson VR; Ayoub GS; Gery I; Clegg DO
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4435-43. PubMed ID: 17003437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
